MEI Pharma, Inc. Human Resources Contracts & Agreements
14 Contracts & Agreements
- Compensation Agreements (1 contract)
- Consulting Agreements (2)
- Employment Agreements (7)
- Retirement Agreements (1)
- Separation Agreements (3)
- Consulting Services Agreement, dated as of August 2, 2024, by and between MEI Pharma, Inc. and David M. Urso (Filed With SEC on November 12, 2024)
- Consulting Services Agreement, dated as of August 2, 2024, by and between MEI Pharma, Inc. and Richard G. Ghalie (Filed With SEC on November 12, 2024)
- Separation and Release Agreement, dated as of August 4, 2024, by and between MEI Pharma, Inc. and David M. Urso (Filed With SEC on November 12, 2024)
- Separation and Release Agreement, dated as of August 3, 2024, by and between MEI Pharma, Inc. and Richard G. Ghalie (Filed With SEC on November 12, 2024)
- Addendum to Employment Agreement between MEI Pharma, Inc. and Justin J. File, dated August 1, 2024 (Filed With SEC on September 19, 2024)
- Employment Agreement between MEI Pharma, Inc. and Richard Ghalie dated January 16, 2024 (Filed With SEC on February 13, 2024)
- Separation and Release Agreement between the Company and Brian Drazba, dated June 16, 2023 (Filed With SEC on July 27, 2023)
- Amended and Restated MEI Pharma, Inc. 2021 Inducement Grant Equity Compensation Plan (Filed With SEC on June 13, 2023)
- Employment Agreement between the Company and Jay File, dated June 9, 2023 (Filed With SEC on June 13, 2023)
- CEO Employment Agreement between the Company and David Urso, dated June 2, 2023 (Filed With SEC on June 2, 2023)
- Amendment 2021-1 dated April 29, 2021, to the Employment letter dated February 17, 2016, between MEI Pharma, Inc. and Richard G. Ghalie (Filed With SEC on September 2, 2021)
- Employment letter dated February 17, 2016, between MEI Pharma, Inc. and Richard G. Ghalie (Filed With SEC on September 2, 2021)
- Transition and Retirement Agreement between Brian G. Drazba and MEI Pharma, Inc., dated as of August 2, 2021 (Filed With SEC on August 5, 2021)
- Amendment No. 1, dated July 12, 2018, to the Employment Letter dated March 6, 2014, between MEI Pharma, Inc. and David M. Urso (Filed With SEC on July 16, 2018)
